Nanobiotix Ownership | Who Owns Nanobiotix?
Nanobiotix Ownership Summary
Nanobiotix is owned by 11.92% institutional investors, and 88.08% retail investors. Johnson & johnson is the largest institutional shareholder, holding 11.76% of NBTX shares. Baillie Gifford Global Discovery A Acc is the top mutual fund, with 3.24% of its assets in Nanobiotix shares.
NBTX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Nanobiotix | 11.92% | - | 88.08% |
| Sector | Healthcare Stocks | 35.58% | 11.87% | 52.55% |
| Industry | Biotech Stocks | 35.80% | 11.85% | 52.35% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Johnson & johnson | 5.62M | 11.76% | $173.61M |
| Blackrock | 239.01K | 0.65% | $1.20M |
| Morgan stanley | 36.27K | 0.08% | $1.12M |
| Optiver b.v. | 13.50K | 0.03% | $416.78K |
| Marshall wace, llp | 9.24K | 0.02% | $285.21K |
| Ubs group | 5.56K | 0.01% | $171.54K |
| Bnp paribas arbitrage, snc | 3.56K | 0.01% | $109.87K |
| Rhumbline advisers | 2.28K | 0.00% | $70.41K |
| Royal bank of canada | 1.82K | 0.00% | $56.00K |
| Bank of america corp /de/ | 760.00 | 0.00% | $3.80K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Johnson & johnson | 5.62M | 26.61% | $173.61M |
| Eversource wealth advisors | 882.00 | 0.00% | $46.50K |
| Gamma investing | 828.00 | 0.00% | $25.56K |
| Marshall wace, llp | 9.24K | 0.00% | $285.21K |
| Optiver b.v. | 13.50K | 0.00% | $416.78K |
| Morgan stanley | 36.27K | 0.00% | $1.12M |
| Rhumbline advisers | 2.28K | 0.00% | $70.41K |
| Bnp paribas arbitrage, snc | 3.56K | 0.00% | $109.87K |
| Tower research capital llc (trc) | 1.00 | - | $31.00 |
| Blackrock | 239.01K | - | $1.20M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Morgan stanley | 36.27K | 0.00% | 13.35K |
| Ubs group | 5.56K | - | 4.03K |
| Gamma investing | 828.00 | 0.00% | 599.00 |
| Bank of america corp /de/ | 760.00 | - | 498.00 |
| Eversource wealth advisors | 882.00 | 0.00% | 368.00 |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Baillie gifford | - | - | -2.87M |
| Perceptive advisors | - | - | -105.05K |
| Blackrock funding, inc. /de | - | - | -51.48K |
| Old mission capital | - | - | -48.47K |
| Millennium management | - | - | -16.87K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Tower research capital llc (trc) | 1.00 | - | 1.00 | $31.00 |
| Citigroup | 1.00 | - | 1.00 | $31.00 |
Sold Out
| Holder | Change |
|---|---|
| Barclays | -4.00 |
| Jpmorgan chase | -256.00 |
| Qube research | -343.00 |
| Geode capital management | -10.18K |
| Goldman sachs group | -10.50K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 15 | 7.14% | 5,698,477 | -0.04% | 11 | 8.24% | 6 | -40.00% | 5 | 400.00% |
| Dec 31, 2025 | 2 | -81.82% | 1,759 | -99.97% | - | 0.00% | 1 | -50.00% | 1 | -75.00% |
| Sep 30, 2025 | 3 | -66.67% | 5,903 | -99.90% | - | 0.01% | 1 | -80.00% | 1 | - |
| Jun 30, 2025 | 9 | -10.00% | 5,645,167 | -2.01% | 11 | 8.04% | 5 | 150.00% | 1 | -75.00% |
| Mar 31, 2025 | 10 | -37.50% | 5,761,181 | -5.04% | 12 | 7.35% | 2 | -80.00% | 4 | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Baillie Gifford Global Discovery A Acc | 1.54M | 3.24% | 8.29K |
| Edinburgh Worldwide Ord | 1.34M | 2.83% | - |
| iShares Biotechnology ETF | 51.48K | 0.11% | -128.00 |
| Fidelity Nasdaq Composite Index | 4.49K | 0.01% | - |
| ActivePassive International Equity ETF | 1.28K | 0.00% | - |
| Steward Values Enhanced International I | 1.05K | 0.00% | -447.00 |
| Financial Trust Europe ValueMomentum | 848.00 | 0.00% | 104.00 |
| FT Tactical Europe ValueMomentum | 408.00 | 0.00% | 364.00 |
NBTX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools